カテゴリ： MarketLine, 企業調査, 南アフリカ

Impala Platinum Holdings Ltd：企業の戦略・SWOT・財務情報

◆英語タイトル：Impala Platinum Holdings Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C11676
◆発行会社（調査会社）：MarketLine
◆発行日：2018年11月
◆ページ数：41
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：南アフリカ
◆産業分野：金属・鉱業
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Impala Platinum Holdings Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Impala Platinum Holdings Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Impala Platinum Holdings Limited (Implats) is a producer of platinum group metals (PMGs). It carries out the mining, refining and marketing of platinum and Platinum Group Metals (PGMs), which include iridium, rhodium, palladium and ruthenium. The company also offers nickel, copper and cobalt. The company conducts its operations on two major PGM bearing ore bodies, Bushveld Complex in South Africa and the Great Dyke in Zimbabwe. The Bushveld Complex consists of Impala Platinum and the Leeuwkop projects, Marula Platinum project and Two Rivers Platinum projects. The Great Dyke has interest in Zimplats project and Mimosa Platinum project. In addition, it offers refining services. Implats is headquartered in Johannesburg, Gauteng, South Africa.

Scope

- Detailed information on Impala Platinum Holdings Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Impala Platinum Holdings Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Impala Platinum Holdings Ltd including a breakdown and examination of key business segments
- Intelligence on Impala Platinum Holdings Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Impala Platinum Holdings Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Impala Platinum Holdings Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Impala Platinum Holdings Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Impala Platinum Holdings Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Impala Platinum Holdings Ltd: Company Overview 9
Impala Platinum Holdings Ltd: Overview and Key Facts 9
Impala Platinum Holdings Ltd: Overview 9
Impala Platinum Holdings Ltd: Key Facts 9
Impala Platinum Holdings Ltd: Key Employees 10
Impala Platinum Holdings Ltd: Key Employee Biographies 11
Impala Platinum Holdings Ltd: Major Products and Services 12
Impala Platinum Holdings Ltd: Company History 13
Impala Platinum Holdings Ltd: Management Statement 15
Impala Platinum Holdings Ltd: Locations and Subsidiaries 17
Impala Platinum Holdings Ltd: Key Competitors 18
Impala Platinum Holdings Ltd: Company Analysis 19
Impala Platinum Holdings Ltd: Business Description 19
Impala Platinum Holdings Ltd: SWOT Analysis 23
Impala Platinum Holdings Ltd: SWOT Overview 23
Impala Platinum Holdings Ltd: Strengths 23
Impala Platinum Holdings Ltd: Weaknesses 24
Impala Platinum Holdings Ltd: Opportunities 24
Impala Platinum Holdings Ltd: Threats 24
Impala Platinum Holdings Ltd: Corporate Financial Deals Activity 26
Impala Platinum Holdings Ltd: Financial Deals Overview 26
Impala Platinum Holdings Ltd: Top Deals 2014 – 2018YTD* 27
Impala Platinum Holdings Ltd: Advisors 28
Impala Platinum Holdings Ltd: Top Financial Advisors 28
Impala Platinum Holdings Ltd: Mergers and Acquisitions 29
Impala Platinum Holdings Ltd: Capital Raising 30
Impala Platinum Holdings Ltd: Recent Developments 31
Impala Platinum Holdings Ltd: News and Events Summary 31
Impala Platinum Holdings Ltd: Business Reorganization 34
Impala Platinum Holdings Ltd: Corporate Governance 35
Impala Platinum Holdings Ltd: Financial Performance 35
Impala Platinum Holdings Ltd: Red Flags/DistressSignals 36
Impala Platinum Holdings Ltd: Regulatory and Legal Events 36
Impala Platinum Holdings Ltd: Strategy and Operations 36
Appendix 39
Contact Us 39
Methodology 39
About MarketLine 40

List of Tables
Table 1: Impala Platinum Holdings Ltd: Key Facts
Table 2: Impala Platinum Holdings Ltd: Key Employees
Table 3: Impala Platinum Holdings Ltd: Company History
Table 4: Impala Platinum Holdings Ltd: Locations and Subsidiaries
Table 5: Impala Platinum Holdings Ltd: Key Competitors
Table 6: Impala Platinum Holdings Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Impala Platinum Holdings Ltd: M&A Average Deal Size - Value (US$m)
Table 8: Impala Platinum Holdings Ltd: Top Deals 2014 - 2018YTD*
Table 9: Impala Platinum Holdings Ltd: Financial Advisor Ranking by Value (US$m)
Table 10: Impala Platinum Holdings Ltd: M&A Volume and Value Trend (2014 - YTD*2018)
Table 11: Impala Platinum Holdings Ltd: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 12: Impala Platinum Holdings Ltd: Capital Raising by Deal Type (2014 - YTD*2018)
Table 13: Impala Platinum Holdings Ltd: News and Events Summary
Table 14: Impala Platinum Holdings Ltd: Business Reorganization
Table 15: Impala Platinum Holdings Ltd: Corporate Governance
Table 16: Impala Platinum Holdings Ltd: Financial Performance
Table 17: Impala Platinum Holdings Ltd: Red Flags/DistressSignals
Table 18: Impala Platinum Holdings Ltd: Regulatory and Legal Events
Table 19: Impala Platinum Holdings Ltd: Strategy and Operations

List of Figures
Figure 1: Impala Platinum Holdings Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Impala Platinum Holdings Ltd: M&A Average Deal Size - Value (US$m)
Figure 3: Impala Platinum Holdings Ltd: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: Impala Platinum Holdings Ltd: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 5: Impala Platinum Holdings Ltd: Capital Raising by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Impala Platinum Holdings Ltd：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Zhejiang Hisoar Pharmaceutical Co Ltd (002099)：製薬・医療：M&Aディール及び事業提携情報
    Summary Zhejiang Hisoar Pharmaceutical Co Ltd (Hisoar) is a pharmaceutical company that offers specialty raw materials, preparations, fine chemicals, dyes and intermediates. The company offers raw drugs such as antibody, anti-virus, sugar-reducing, cardiovascular and worm-driven drugs. It produces f …
  • GAIL (India) Ltd (GAIL)-エネルギー分野：企業M&A・提携分析
    Summary GAIL (India) Ltd (GAIL) is a vertically integrated gas company that carries out exploration and production, transmission of natural gas. It also has presence in petrochemical, liquid hydrocarbons and power and renewable sectors. GAIL is also a major LPG transmission company, besides managing …
  • Taiheiyo Cement Corporation：企業の戦略・SWOT・財務分析
    Taiheiyo Cement Corporation - Strategy, SWOT and Corporate Finance Report Summary Taiheiyo Cement Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Syndax Pharmaceuticals Inc (SNDX)：医療機器：M&Aディール及び事業提携情報
    Summary Syndax Pharmaceuticals Inc (Syndax) is a biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The company’s lead product candidate includes entinostat, an oral, small molecule drug candidate, which is in phase 3 clinical trial used for the tre …
  • Pulse Seismic Inc (PSD)：企業の財務・戦略的SWOT分析
    Summary Pulse Seismic Inc (Pulse), formerly Pulse Data Inc is a provider of seismic data library for oil and gas exploration. The company acquires, markets and licenses 2D and 3D seismic data to the western Canadian energy sector. It offers services such as project cost tracking, scouting, geophysic …
  • CITIC Limited：企業の戦略・SWOT・財務情報
    CITIC Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Dohler GmbH：企業の戦略・SWOT・財務分析
    Dohler GmbH - Strategy, SWOT and Corporate Finance Report Summary Dohler GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Vietnam National Petroleum Group (PLX)：企業の財務・戦略的SWOT分析
    Vietnam National Petroleum Group (PLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Shanghai Kehua Bio-engineering Co Ltd (002022)：製薬・医療：M&Aディール及び事業提携情報
    Summary Shanghai Kehua Bio-engineering Co Ltd (KHB) is a medical device company that develops, manufactures and markets in vitro diagnostic devices and related products. The company’s major product portfolio includes enzyme immunoassay kits, clinical chemistry reagents, PCR kits, rapid test kits, ch …
  • GraIncorp Ltd (GNC)：企業の財務・戦略的SWOT分析
    Summary GraIncorp Ltd (GrainCorp) is a grain supply company that provides storage services. The company offers services such as storage, marketing, handling, and logistics services to the grain growing industry. It also provides services such as research and development and commercialization; seed b …
  • Thrive Bioscience Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Thrive Bioscience Inc (Thrive Bioscience) is a life science company that provides automated non-microbial cell culture instruments. The company’s cell culture systems provide scalable cell propagation, analytics, reproducible protocols, and complete process history documentation with the ima …
  • NV Nederlandse Gasunie：企業の戦略的SWOT分析
    NV Nederlandse Gasunie - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • International Business Machines Corp (IBM)：企業の財務・戦略的SWOT分析
    International Business Machines Corp (IBM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • BASF SE：戦略・SWOT・企業財務分析
    BASF SE - Strategy, SWOT and Corporate Finance Report Summary BASF SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Adverum Biotechnologies Inc (ADVM)：製薬・医療：M&Aディール及び事業提携情報
    Summary Adverum Biotechnologies Inc (Adverum), formerly Avalanche Biotechnologies Inc, is a clinical-stage gene therapy provider. The company’s product pipeline includes AVDM-053, ADVM-022 and AVA-311. Its products are used for treatment of antitrypsin deficiency, hereditary angioedema, wet age-rela …
  • VAMED AG：企業の戦略・SWOT・財務情報
    VAMED AG - Strategy, SWOT and Corporate Finance Report Summary VAMED AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • AcelRx Pharmaceuticals Inc (ACRX)：企業の財務・戦略的SWOT分析
    AcelRx Pharmaceuticals Inc (ACRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Woori Bank：企業のM&A・事業提携・投資動向
    Woori Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Woori Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Mizuho Trust & Banking Co Ltd：企業の戦略・SWOT・財務分析
    Mizuho Trust & Banking Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Mizuho Trust & Banking Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Kuwait Oil Co：企業の戦略的SWOT分析
    Kuwait Oil Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆